ArticleBiophysical journal2007
Effect of transjunctional KCl gradients on the spermine inhibition of connexin40 gap junctions.
Article in Biophysical journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- The Polyamine Spermine Potentiates the Propagation of Negatively Charged Molecules through the Astrocytic Syncytium.Biomolecules · 2022Article
- Functional formation of heterotypic gap junction channels by connexins-40 and -43.Channels (Austin, Tex.) · 2014Article
- Interfering amino terminal peptides and functional implications for heteromeric gap junction formation.Frontiers in pharmacology · 2013Article
- Gating of connexin 43 gap junctions by a cytoplasmic loop calmodulin binding domain.American journal of physiology. Cell physiology · 2012Article
- Connexin40 and connexin43 determine gating properties of atrial gap junction channels.Journal of molecular and cellular cardiology · 2010Article
- Mammalian polyamine metabolism and function.IUBMB life · 2009Review
- Mouse models to investigate the function of spermine.Communicative & integrative biology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Spermine inhibits rat connexin40 (Cx40) gap junctions. Glutamate residues at positions 9 and 13 and a basic amino acid (HKH) motif at positions 15-17 on the amino terminal domain are essential for this inhibitory activity. Questions remain as to whether spermine occludes the channel within the ion permeation pathway. To examine this question, cis or trans [KCl] was systematically lowered and the equilibrium dissociation constants (K(d)) and kinetics of unilateral spermine block on wild-type Cx40 gap junctions were determined. Asymmetric reductions in the trans [KCl] produced noticeable asymmetric shifts in the V(1/2) and G(min) values that progressively resembled G(j)-V(j) relationships observed in heterotypic connexin gap junction combinations. As cis or trans [KCl] was reduced by 25%, 50%, or 75% relative to the spermine-containing side, the transjunctional voltage (V(j))-dependent K(d) values increased or decreased, respectively. The spermine on-rates and off-rates, calculated from the junctional current decay and recovery time constants, were similarly affected. Hill coefficients for the spermine dose-response curves were approximately 0.58, indicative of negative cooperativity and possible multiple spermine inhibitory sites. The equivalent "electrical distance" (delta) ranged from 0.61 at 25% cis [KCl] to 1.4 at 25% trans [KCl], with a Hill coefficient of 1.0. Symmetrical reductions in [KCl] resulted in intermediate decreases in the spermine K(d)s, indicative of a minor electrostatic effect and a more significant effect of the transjunctional KCl electrodiffusion potential on the spermine association and dissociation rates. These data are consistent with a single spermine molecule being sufficient to occlude the Cx40 gap junction channel within the KCl permeation pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.